CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Maravai Lifesciences Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Maravai Lifesciences Holdings Inc
10770 Wateridge Circle Suite 200
Suite 200
Phone: (858) 546-0004p:858 546-0004 SAN DIEGO, CA  92121  United States Ticker: MRVIMRVI
Business Summary
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various industries, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Robert AndrewEckert 63 12/5/2024 12/5/2024
Chief Executive Officer, Director WilliamMartin 49 7/31/2024 9/30/2022
Chief Financial Officer Kevin M.Herde 52 4/1/2017 4/1/2017
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
TriLink Biotechnologies, LLC 10770 Wateridge Circle San Diego CA United States
MyChem, LLC 9215 Brown Deer Road San Diego CA United States

Business Names
Business Name
Alphazyme, LLC (Delaware)
Cygnus Technologies, LLC (Delaware)
Glen Research, LLC (Delaware)
10 additional Business Names available in full report.

General Information
Number of Employees: 580 (As of 9/30/2024)
Outstanding Shares: 252,527,585 (As of 11/7/2024)
Shareholders: 3
Stock Exchange: NASD
Federal Tax Id: 852786970
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025